GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Dr Hoenle AG (XTER:HNL) » Definitions » COGS-to-Revenue

Dr Hoenle AG (XTER:HNL) COGS-to-Revenue : 0.40 (As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Dr Hoenle AG COGS-to-Revenue?

Dr Hoenle AG's Cost of Goods Sold for the three months ended in Dec. 2023 was €9.5 Mil. Its Revenue for the three months ended in Dec. 2023 was €23.8 Mil.

Dr Hoenle AG's COGS to Revenue for the three months ended in Dec. 2023 was 0.40.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Dr Hoenle AG's Gross Margin % for the three months ended in Dec. 2023 was 59.92%.


Dr Hoenle AG COGS-to-Revenue Historical Data

The historical data trend for Dr Hoenle AG's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Hoenle AG COGS-to-Revenue Chart

Dr Hoenle AG Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.32 0.36 0.40 0.45 0.50

Dr Hoenle AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.39 0.38 0.81 0.41 0.40

Dr Hoenle AG COGS-to-Revenue Calculation

Dr Hoenle AG's COGS to Revenue for the fiscal year that ended in Sep. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=52.995 / 106.342
=0.50

Dr Hoenle AG's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=9.535 / 23.787
=0.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dr Hoenle AG  (XTER:HNL) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Dr Hoenle AG's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 9.535 / 23.787
=59.92 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Dr Hoenle AG COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Dr Hoenle AG's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr Hoenle AG (XTER:HNL) Business Description

Traded in Other Exchanges
Address
Nicolaus-Otto-Street 2, Gilching, Munich, BY, DEU, 82205
Dr Hoenle AG supplies industrial UV technology. It operates in three business segments: The Equipment and Systems segment, which accounts for the majority of revenue, includes devices for UVC air and surface disinfection, and it is used for drying inks and coatings, for curing adhesives and plastics, and for solar simulation. The Glass and Lamps segment includes the development, production, and sale of tubing and semi-finished goods made of quartz glass as well as the manufacture of UV medium?pressure and low-pressure lamps. Adhesives segment, which includes industrial adhesives designed for a broad spectrum of applications such as electronics, medical technology, optics, and glass processing. The company generates the majority of its revenue from sales in other countries.

Dr Hoenle AG (XTER:HNL) Headlines

No Headlines